Siskind, D., Russell, A. W., Suetani, S., Flaws, D., Kisely, S., Moudgil, V., Northwood, K., Robinson, G., Scott, J. G., Stedman, T., Warren, N., Winckel, K., Cosgrove, P., & Baker, A. (2021). CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine. Therapeutic Advances in Psychopharmacology, 11. https://doi.org/10.1177/20451253211045248
CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine. / Siskind, Dan; Russell, Anthony W.; Suetani, Shuichi et al.
In:
Therapeutic Advances in Psychopharmacology, Vol. 11, 2021.
Research output: Contribution to journal › Article › peer-review
Siskind, D, Russell, AW, Suetani, S, Flaws, D, Kisely, S, Moudgil, V, Northwood, K, Robinson, G, Scott, JG, Stedman, T, Warren, N, Winckel, K, Cosgrove, P & Baker, A 2021, 'CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine', Therapeutic Advances in Psychopharmacology, vol. 11. https://doi.org/10.1177/20451253211045248
Siskind D, Russell AW, Suetani S, Flaws D, Kisely S, Moudgil V et al. CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine. Therapeutic Advances in Psychopharmacology. 2021;11. doi: 10.1177/20451253211045248
Siskind, Dan ; Russell, Anthony W. ; Suetani, Shuichi et al. / CoMET : a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine. In: Therapeutic Advances in Psychopharmacology. 2021 ; Vol. 11.
@article{5b0cde13424148ce806a8a76f57e30b4,
title = "CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine",
keywords = "clozapine, metformin, obesity, randomised controlled trial",
author = "Dan Siskind and Russell, {Anthony W.} and Shuichi Suetani and Dylan Flaws and Steve Kisely and Vikas Moudgil and Korinne Northwood and Gail Robinson and Scott, {James G.} and Terry Stedman and Nicola Warren and Karl Winckel and Peter Cosgrove and Andrea Baker",
note = "Publisher Copyright: {\textcopyright} The Author(s), 2021.",
year = "2021",
doi = "10.1177/20451253211045248",
language = "English",
volume = "11",
journal = "Therapeutic Advances in Psychopharmacology",
issn = "2045-1253",
publisher = "SAGE Publications Inc.",
}
TY - JOUR
T1 - CoMET
T2 - a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine
AU - Siskind, Dan
AU - Russell, Anthony W.
AU - Suetani, Shuichi
AU - Flaws, Dylan
AU - Kisely, Steve
AU - Moudgil, Vikas
AU - Northwood, Korinne
AU - Robinson, Gail
AU - Scott, James G.
AU - Stedman, Terry
AU - Warren, Nicola
AU - Winckel, Karl
AU - Cosgrove, Peter
AU - Baker, Andrea
N1 - Publisher Copyright:
© The Author(s), 2021.
PY - 2021
Y1 - 2021
KW - clozapine
KW - metformin
KW - obesity
KW - randomised controlled trial
UR - http://www.scopus.com/inward/record.url?scp=85132578224&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132578224&partnerID=8YFLogxK
U2 - 10.1177/20451253211045248
DO - 10.1177/20451253211045248
M3 - Article
AN - SCOPUS:85132578224
SN - 2045-1253
VL - 11
JO - Therapeutic Advances in Psychopharmacology
JF - Therapeutic Advances in Psychopharmacology
ER -
